Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2003
11/13/2003US20030211569 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211564 Comprises element for separating erythrocytes from plasma, a protease layer, and ketoamine oxidase signal producing system layer
11/13/2003US20030211563 Human testis specific serine/threonine kinase 1 & 2
11/13/2003US20030211557 Immunoassay for detecting creutzfeldt-jocab diseases
11/13/2003US20030211556 Marker for psychiatric conditions
11/13/2003US20030211555 Assay for evaluation of cellular response to allergens
11/13/2003US20030211554 Using monoclonal and/or polyclonal to screen vascular or mammary gland tissue for lysosomal pepstatin-insensitive proteinase activity; cancer diagnosis
11/13/2003US20030211552 Cyclic GMP dependent protien kinase as a chemotherapeutic target for antiprotozoal agents
11/13/2003US20030211551 Bioassay comprising ligands such as von Willebrand factor, collagen, and thrombin which uses oscillating or magnetic rotating fields to monitoring platelet function
11/13/2003US20030211550 Microarray comprising different monoclonal antibodies for the concurrent detection and quantification of colony stimulating factors, interleukins, cellular adhesion and interferons in sample
11/13/2003US20030211548 Nonradioactive assay to monitor and quantify target-cell killing activities mediated by cytotoxic T lymphocytes
11/13/2003US20030211547 Large conductance calcium-dependent potassium channel as modulator of alcohol effects and consumption
11/13/2003US20030211546 Identifying bioactive agent/enzyme inhibitors capable of interfering with the binding of protein phosphatase 5 (PP5) to RAD protein; antitumor agents
11/13/2003US20030211545 Using enzyme inhibitors to treat neuropsychological disorders such as schizophrenia and bipolar disorder; neuroleptic agents
11/13/2003US20030211544 Facilitating the recovery of troponins; immunoassays; diagnosing myocardial infarction
11/13/2003US20030211542 Assays and methods of diagnosis and treatment based on use of sodium channels as targets for amyloid beta or its aggregates
11/13/2003US20030211541 Using immunological means to identify growth differentiation factor-14 (GDF-14) for treating cell proliferative and immunological disorders; gene expression inhibition; antiproliferative agents
11/13/2003US20030211534 Stellar icon for data representation and system and method forming the stellar icon
11/13/2003US20030211533 Method for testing a therapeutic or preventive agent for hyperlipidemia
11/13/2003US20030211531 Methods for discovering tumor biomarkers and diagnosing tumors
11/13/2003US20030211529 Human Eag2
11/13/2003US20030211524 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
11/13/2003US20030211523 Using green fluorescent protein to detect polypeptide interactions in cells; high throughout assay
11/13/2003US20030211519 Identifying angiogenesis inhibitor for treating cell proliferative disorders; antitumor agents
11/13/2003US20030211518 Methods for identifying and monitoring patients at risk for systemic inflammatory conditions, methods for selecting treatments for these patients and apparatus for use in these methods
11/13/2003US20030211515 Comprises nucleotide sequences coding matrix protein for diagnosing and treating cancer
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211507 Microscale diffusion immunoassay in hydrogels
11/13/2003US20030211503 Using concentration of zinc finger protein (WT1) to detect cancer in children
11/13/2003US20030211499 Transporters and ion channels
11/13/2003US20030211496 Kit for calibrating solid supports/matrices associated with polynucleotide hybridization methodologies; genetic analysis
11/13/2003US20030211495 Identifying peptide that partially or completely inhibits interaction between two or more binding partners; competitive binding; high throughput assays; drug screening
11/13/2003US20030211493 Comprises membrane protein for diagnosis, prevention and treatment of infections, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
11/13/2003US20030211488 Nanoparticle probs with Raman spectrocopic fingerprints for analyte detection
11/13/2003US20030211486 Compositions and methods for detecting polymorphisms associated with pigmentation
11/13/2003US20030211480 Molecular interaction assays on a solid surface
11/13/2003US20030211477 Carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) structure and uses thereof in drug identification and screening
11/13/2003US20030211475 Monitoring reporter gene expression/transcriptional activity in the ergosterol and protein kinase c pathway of cell; gene expression inhibition; antitumor agents; drug screening
11/13/2003US20030211471 Method for detecting ligands and targets in a mixture
11/13/2003US20030211468 Comprises monoclonal antibody which deactivates kaposi's sarcoma associated herpesvirus interleukin-6 (KSRV VIL-6) for treating, diagnosing and prognosing oncogenic viral infections; antiarthritic agents; antitumor agents
11/13/2003US20030211467 Using monoclonal antibody for diagnosis, prevention and treatment of viral infections; immunotherapy; genetic vaccine
11/13/2003US20030211466 Using cells messenger RNA expression profile to diagnose infections or metabolic disorders
11/13/2003US20030211464 Method and compositions for drug discovery
11/13/2003US20030211461 Using optical gradients and cell displacement to detect tyrosine kinase inhibitors; enzyme inhibitors; drug dcreening
11/13/2003US20030211460 Methods for detecting activity of clottings factors
11/13/2003US20030211459 Using magnetic resonance imaging to monitor nervous system activity after exposure to agents for treatment of brain, pain and psychiatric illnesses
11/13/2003US20030211457 Methods and kits for testing mutagenicity
11/13/2003US20030211454 Detection reagent
11/13/2003US20030211111 Antibodies to biological membranes
11/13/2003US20030211105 Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity
11/13/2003US20030211101 Vascular endothelial growth factor-like protein from ORF viruses binds and activates mammalian VEGF receptor-2, and uses thereof
11/13/2003US20030211099 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2
11/13/2003US20030211092 Genetic engineering; gene expression; culture product
11/13/2003US20030211091 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/13/2003US20030211086 Minicell-based selective absorption
11/13/2003US20030211041 Water monitoring system using bivalve mollusks
11/13/2003US20030211040 Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain
11/13/2003US20030211039 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
11/13/2003US20030211013 Apparatus for detection and analysis of DNA on microarrays
11/13/2003US20030211008 Coagulation time test
11/13/2003US20030211007 Diagnosis of heart disease
11/13/2003US20030211006 Hydrophobic fluid flow delay layer; applying solvent; medical diagnosis
11/13/2003US20030210287 Microdroplet dispensing methods for a medical diagnostic device
11/13/2003US20030210046 Method for high resolution magnetic resonance analysis using magic angle technique
11/13/2003US20030209663 Method for measuring total concentration of carbon monoxide and hydrocarbons in oxygen by ion mobility spectrometry
11/13/2003US20030209653 Sample collection and testing system
11/13/2003US20030209451 Microfluidic ion-selective electrode sensor system
11/13/2003US20030209442 Electrochemical cell
11/13/2003US20030209434 Current-biased potentiometric NOx sensor for vehicle emissions
11/13/2003US20030209432 Methods and compositions relating to electrical detection of nucleic acid reactions
11/13/2003US20030209427 Method and apparatus for manufacturing colloidal rod particles
11/13/2003US20030209144 Collection of dissolved gases from groundwater
11/13/2003US20030209098 Apparatus for orienting tablets
11/13/2003US20030209057 Controlling particle size of powder; mixing, heating metal particles in matrix
11/13/2003US20030209053 Golf ball COR testing machine
11/13/2003CA2652991A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
11/13/2003CA2491708A1 Non-viral gene delivery system
11/13/2003CA2485099A1 Apparatus including ion transport detecting structures and methods of use
11/13/2003CA2485093A1 Substituted imidazole derivatives: gabaa receptor ligands
11/13/2003CA2485089A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/13/2003CA2484920A1 Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression
11/13/2003CA2484730A1 Device and method for analytical cell imaging
11/13/2003CA2484600A1 Therapeutic use of selective pde10 inhibitors
11/13/2003CA2484529A1 Process for the monitoring of contaminant removal during the purification process of a pharmaceutical product produced by a host cell
11/13/2003CA2484499A1 Short enzyme donor fragment
11/13/2003CA2484312A1 Catechin multimers as therapeutic drug delivery agents
11/13/2003CA2484187A1 Human adipocyte cell populations and methods for identifying modulators of same
11/13/2003CA2484153A1 Methods for discovering tumor biomarkers and diagnosing tumors
11/13/2003CA2483958A1 Pregnancy detection
11/13/2003CA2483585A1 Test strip and method for determining concentration of creatinine in a body fluid
11/13/2003CA2483408A1 Sandwich assay and kit
11/13/2003CA2483189A1 Device for closure of a vascular defect
11/13/2003CA2483053A1 Human papillomavirus multiplexed assay
11/13/2003CA2482967A1 Binary or polynary targeting and uses thereof
11/13/2003CA2482525A1 Method for characterizing water-in-oil emulsions using electrical wave forms
11/13/2003CA2481094A1 Ray-based image analysis for biological specimens
11/13/2003CA2477985A1 Time-resolved fluorescence assay for the detection of multimeric forms of a-.beta. or other aggregating polypeptides
11/12/2003EP1361439A1 Screening for peptides inhibiting PP1c binding to Bcl-2, BCL-Xl and BCL-W proteins
11/12/2003EP1361438A1 Solid-phase assisted spectroscopic and spectrometric analysis of complex peptide mixes
11/12/2003EP1361437A1 A novel biological cancer marker and methods for determining the cancerous or non-cancerous phenotype of cells
1 ... 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 ... 3937